Endocyte Inc (ECYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,559 | 31,228 | 15,432 | 45,533 | 52,847 |
| Marketable Securities | 78,912 | 106,979 | 158,169 | 79,536 | 70,434 |
| Receivables | 273 | 55 | 9 | 706 | 6,353 |
| Other current assets | 77 | 256 | 494 | 653 | 496 |
| TOTAL | $98,573 | $140,256 | $174,876 | $127,038 | $133,332 |
| Non-Current Assets | |||||
| PPE Net | 2,182 | 3,205 | 3,398 | 3,971 | 3,839 |
| Investments And Advances | 0 | 0 | 0 | 81,761 | 25,572 |
| Other Non-Current Assets | 7 | 34 | 112 | 31 | 115 |
| TOTAL | $2,190 | $3,239 | $3,510 | $85,763 | $29,526 |
| Total Assets | $100,762 | $143,494 | $178,386 | $212,801 | $162,858 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 376 | 1,382 | 1,263 | 1,235 | 5,436 |
| Accrued Expenses | 4,170 | 4,181 | 4,926 | 5,650 | 8,463 |
| Other current liabilities | N/A | N/A | N/A | N/A | 18 |
| TOTAL | $4,546 | $5,562 | $6,189 | $6,885 | $73,664 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 59,747 |
| Other Non-Current Liabilities | 0 | 3 | 19 | 30 | 34 |
| TOTAL | $732 | $785 | $850 | $912 | $965 |
| Total Liabilities | $5,278 | $6,347 | $7,039 | $7,797 | $74,629 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,350 | 42,471 | 42,153 | 41,887 | 36,181 |
| Common Shares | 48 | 42 | 42 | 42 | 36 |
| Retained earnings | -308,955 | -253,623 | -209,735 | -168,465 | -173,925 |
| Other shareholders' equity | -64 | -41 | -79 | -144 | 57 |
| TOTAL | $95,484 | $137,147 | $171,346 | $205,004 | $88,229 |
| Total Liabilities And Equity | $100,762 | $143,494 | $178,386 | $212,801 | $162,858 |